Skincare peptide innovation moves at lightning speed. New peptides, advanced delivery systems, and proprietary blends launch almost monthly, making it tough to separate breakthroughs from hype. Recently, I heard a TikTok claim that after age 40, we retain only 35% of our fibroblasts, dropping to 90% fewer receptors by the age of 80+, rendering peptides ineffective for mature skin. Let's unpack this scientifically as this is a bit oversimplified clickbait, even though it’s accurate that peptide efficacy varies. BUSTING THE AGE MYTH [1-4] Fibroblasts naturally decline as we age. Menopause speeds this up through estrogen loss (collagen drops 2.1%/year afterward). Cells shrink, divide less often, produce less collagen and other proteins, and release more wrinkle-causing enzymes like MMPs (Matrix metalloproteinases are enzymes that break down extracellular matrix proteins like collagen and elastin). Receptor responsiveness decreases (TGF-β signaling down 30-50% in 60+ skin). Aging and menopause affect skin through: ▌ Senescence markers (p16/p21) increase, thus more “zombie cells” ▌ Reduced receptor signaling (TGF-β, estrogen receptors less responsive) ▌ Stiffer extracellular matrix ▌ Lower ceramides and hyaluronic acid from fibroblasts (thinner barrier, drier or dehydrated skin) However, it's not a complete shutdown. Fibroblasts from 70-90-year-olds still respond to peptides in lab studies. Menopause mainly worsens skin barrier delivery. 5 REAL REASONS PEPTIDES VARY IN EFFICACY Here's why the same formula or peptide might work for your bestie's skin but leave yours unchanged. 1. Receptor & signaling differences Your fibroblasts' receptor density (TGF-β, integrins) varies by genetics, UV history, and inflammation. Photoaged skin shows 30-50% weaker responses. Senescent (zombie) cells prioritize survival over collagen production [1]. 2. Skin barrier roadblocks Compromised barriers (atopic, over-exfoliated, aged) reduce peptide delivery. Stratum corneum dysfunction limits penetration, especially in sensitive/aged skin [5]. 3. Protease degradation Skin enzymes chew up peptides before they reach targets. Inflamed or mature skin has higher protease activity, slashing bioavailability of peptides [6]. Read more about the proteasome. 4. Dose & vehicle mismatch Lab studies use precise 0.005-3% concentrations with optimal pH/stability. Real products may underdose peptides or use unstable watery bases, reducing in vivo results. Efficacy depends on concentration, delivery system, and formulation stability [5]. 5. Your damage profile Your damage profile matters. Heavily UV‑exposed or smoker’s skin tends to benefit more from senotherapeutic peptides, which have been shown to reduce p16/p21 and overall senescence burden in aged or photo‑damaged skin models. Skin with milder, early aging changes often responds very well to matrikine peptides, which significantly increase collagen and other extracellular matrix components in vitro and improve wrinkles in clinical studies. A single peptide strategy rarely fits every skin type or damage pattern [1]. OPTIMISING THE SKIN ENVIRONMENT In practice, combining barrier repair, retinoids (including retinaldehyde), and targeted procedures with well‑formulated peptide serums gives aging skin more “cellular machinery” to respond. Topical retinoids do not simply “switch peptide receptors back on”; they increase fibroblast proliferation, boost TGF‑β‑mediated collagen synthesis in damaged skin, and normalise matrix turnover, effectively making the remaining fibroblasts more responsive to peptide signals [9]. Retinaldehyde (or retinal) offers a gentler but still biologically active route to retinoic acid, improving collagen and epidermal renewal with better tolerability, which makes it particularly suitable for mature or sensitised skin when combined with peptides. Procedures like fractional microneedle radiofrequency and fractional lasers reduce senescent fibroblasts and expand the pool of newly proliferated, non‑senescent fibroblasts, creating a rejuvenated dermal environment where senotherapeutic and matrikine peptides can act more efficiently [10]. WHAT ARE MATRIKINES Matrikines are small peptide fragments naturally released from extracellular matrix proteins (collagen, elastin, laminin) during tissue repair or aging breakdown. They act as "messenger signals" that tell skin cells (especially fibroblasts) to: ▌Produce more collagen, fibronectin, hyaluronic acid ▌Rebuild the skin's structural framework ▌Repair damage at wound sites or aging areas Cosmetic matrikines (like Palmitoyl Tripeptide-38, Matrixyl 3000, Hexapeptide-9) are synthetic versions of these natural fragments. The palmitoyl chain helps them penetrate skin to mimic this repair signaling. DO THEY WORK BETTER YOUNG VS. MATURE? Not really. It's mechanism-dependent. Classical collagen peptides (Matrixyl 3000, Pal-Tripeptide-38) boost ECM across ages, though absolute gains are bigger in proliferative young fibroblasts. Senotherapeutics shine in older skin, clearing senescence for 40-60% marker reduction where damage is highest [8]. Clinical trials show wrinkle reduction (20-45%) across adult ages. Response varies by individual skin biology rather than chronological age [6]. Chronological age is the years since your birth (calendar age). Biological age is how old your cells and tissues function (health-driven age). A healthy 60-year-old may have a biological age of 45, while a stressed smoker at 40 could be biologically 55. PEPTIDE EFFICACY VARIES Peptide effectiveness differs due to individual variations in fibroblast receptor density, skin barrier permeability, and baseline senescence levels. Aged or photo-damaged skin shows reduced TGF-β signaling responsiveness (down 30-50% in 60+ vs 20-30 year olds) and higher protease activity that degrade peptides before cellular uptake. Chronic inflammation elevates SASP factors that impair peptide signaling, while stratum corneum changes limit delivery in barrier-compromised skin. Senotherapeutic peptides show stronger relative benefits in older cells (p16/p21 down by 40-60%) since they target accumulated damage, while collagen peptides produce more absolute collagen gains in younger, proliferative fibroblasts. Bottom line: Response exists across ages but varies by damage burden and peptide mechanism. Multi-peptide formulations addressing senescence + ECM + inflammation optimize outcomes for diverse skin ages [7]. TAKEAWAY Peptides work. They're real science. Your skin's unique biology means results vary. Match the right type to your needs: matrikines for prevention, senotherapeutics for repair, anti-inflammatories for sensitivity. Multi-peptide skincare products with good barrier support work best for most. Pair them with retinoids and, when appropriate, rejuvenating in‑office procedures to create a more receptive fibroblast environment. Swap single-target for “broad-spectrum” formulas. Examples of multi-peptide and multi-target formula´s are: Educated Mess Multi-Peptide Serum, Medik8 Liquid Peptides (a personal favourite), The Ordinary Multi-Peptide + HA Serum ("Buffet"), No7 Future Renew Damage Reversal Serum, SkinMedica TNS Advanced+ Serum, and Paula's Choice Peptide Booster. Take care! Anne-Marie References [1] Zonari et al., npj Aging 2023;9:10 (peptide response in aged fibroblasts) [2] Varani et al., J Invest Dermatol 2006;126:1140-9 (2.1% collagen loss confirmed) [3] Fisher et al., NEJM 2005;352:657-64 (senescence markers, TGF-β decline range) [4] Brincat et al., Obstet Gynecol 1987;70:820-3 (estrogen receptors, barrier effects) [5] Resende et al., Pharmaceuticals 2021;14:702 (peptide penetration in compromised barriers) [6] Nguyen et al., J Clin Aesthet Dermatol 2021;14:14-21 (peptide efficacy/skin aging) [7] Li et al., J Cosmet Dermatol 2023;doi:10.1111/jocd.15849 (multi-peptide eye serum efficacy) [8] Pintea et al., Biomolecules 2025;15:88 (skin senescence peptides) [9] Harper et al., Exp Cell Res 1988;178:254–63 (retinoic acid synergism with EGF in adult human fibroblast growth) [10] Hwang et al., Sci Rep 2025;15:18296 (fractional MNRF reduces senescent fibroblasts and boosts collagen/elastin in aged skin)
Comments
|
CategoriesAll Acne Age Clocks Ageing Aquatic Wrinkles Armpits Autophagy Biostimulators Blue Light & HEVIS Circadian Rhythms Cleansing Collagen CoQ10 Cosmetic Intolerance Syndrome Couperose Deodorant Dermaplaning Diabetes DNA Damage DNA Repair Dry Skin Epigenetics Epigenome Evidence Based Skin Care Exfoliation Exosomes Exposome Eyes Face Or Feet? Facial Blushing Facial Flushing Facial Oils Ferroptosis Fibroblast Fingertip Units Gendered Ageism Genome Glycation Growth Factors Gua Sha Hair Hair Removal Hallmark Of Aging Healthy Skin Heat Shock Proteins Hormesis Humidity Hyaluron Hyaluronidase Hypo-allergenic Indulging Inflammasome Interactome Jade Roller Keratinocytes Licochalcone A Lipid Peroxidation Luxury Skin Care Lymphatic Vessel Ageing Malar Oedema Matrikines Menopause Microbiome Mitochondrial Dysfunction Mood Boosting Skin Care Neurocosmetics Oily Skin Ox Inflammageing Peptides PH Balance Skin Photo Biomodulation Polynucleotides Proteasome Proteome Psoriasis Purging Regeneration Regenerative Treatments Review Rosacea Safety Scarring Sensitive Skin Skin Care Regimen Skin Flooding Skin Hydration Skin Senescence Skip-Care Sleep Slugging Sunscreen Tanning Under Eye Bags UV Index Vitamin C Vitamin D Well Ageing Skin Care Wound Healing Wrinkles
Archives
February 2026
|
|
Anne-Marie van Geloven © 2024 All rights reserved
|


RSS Feed